找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Bone Tumors; Evidence-based Appro Jayasree Kattoor,Sindhu Nair P,Jayasree Geothe Book 2024 The Editor(s) (if applicable) and The Author(s),

[復制鏈接]
樓主: Gram114
31#
發(fā)表于 2025-3-26 23:48:03 | 只看該作者
Liat Margolis,Alexander RobinsonVascular tumours of bone comprise benign, intermediate and malignant tumours. Even benign tumours can be clinically and radiologically aggressive. Epithelioid haemangioendothelioma used to be in the intermediate group, but is now considered as malignant. Specific molecular markers are identified for each entity.
32#
發(fā)表于 2025-3-27 03:16:49 | 只看該作者
https://doi.org/10.1007/978-3-7643-8297-1Adamantinomas are rare tumours with a biphasic histology. Epithelial islands are set in fibrous tumours. >80% occur in tibia. These are locally aggressive tumours. New classification includes OFD-like adamantinoma, classic adamantinoma and dedifferentiated adamantinoma.
33#
發(fā)表于 2025-3-27 05:55:31 | 只看該作者
34#
發(fā)表于 2025-3-27 11:38:12 | 只看該作者
https://doi.org/10.1007/978-3-7643-8297-1In this chapter, extremely rare benign and malignant tumours are included. Many of these tumours are common in soft tissue, but its osseous counterparts are rare. They are included in this book because rarely such tumours are encountered in daily practice.
35#
發(fā)表于 2025-3-27 17:33:29 | 只看該作者
Liat Margolis,Alexander RobinsonTumour-like lesions of bone pose diagnostic difficulty in differentiating from tumours. The entities included in this chapter are Paget disease, osteomyelitis, hamartoma, mastocytosis, hyperparathyroidism, osteopetrosis, etc.
36#
發(fā)表于 2025-3-27 19:30:57 | 只看該作者
37#
發(fā)表于 2025-3-28 00:03:31 | 只看該作者
Primary Bone Tumours,Primary bone tumours are very rare. The tumours arise de novo or secondary to some pre-existing conditions of bone. There are many syndromes associated with bone tumours. This chapter gives the classification and staging of bone sarcoma and the syndromes associated with different bone tumours.
38#
發(fā)表于 2025-3-28 02:41:38 | 只看該作者
39#
發(fā)表于 2025-3-28 08:14:04 | 只看該作者
40#
發(fā)表于 2025-3-28 13:03:13 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
鲜城| 宁蒗| 尚志市| 徐州市| 武威市| 泗阳县| 新民市| 青铜峡市| 特克斯县| 郸城县| 广州市| 乾安县| 新平| 嘉祥县| SHOW| 南康市| 红河县| 泾源县| 通化市| 延长县| 牡丹江市| 镇康县| 巴林右旗| 榕江县| 出国| 布拖县| 稷山县| 阳春市| 通道| 阿克陶县| 永康市| 辉南县| 松桃| 长白| 屯门区| 广丰县| 新干县| 松阳县| 望城县| 忻城县| 永平县|